1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine

Term ID

CHEBI:79103

Synonyms

1-palmitoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine
O-{[(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}-L-serine
Phosphatidylserine(16:0/22:6)
Phosphatidylserine(16:0/22:6n3)
Phosphatidylserine(16:0/22:6w3)
Phosphatidylserine(38:6)
PS(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PS(16:0/22:6)
PS(16:0/22:6n3)
PS(16:0/22:6w3)
PS(38:6)
PSer(16:0/22:6)
PSer(16:0/22:6n3)
PSer(16:0/22:6w3)
PSer(38:6)

Definition

A 3-sn-phosphatidyl-L-serine in which the phosphatidyl acyl groups at positions 1 and 2 are specified as octadecanoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.

References

HMDB:HMDB0012362
LIPID_MAPS_instance:LMGP03010043

Ontology

ChEBI ( EBI )

Relationships

is a type of: 3-sn-phosphatidyl-L-serine

3-sn-phosphatidyl-L-serine Show first 5 Terms
has_functional_parent: all-cis-docosa-4,7,10,13,16,19-hexaenoic acid hexadecanoic acid

all-cis-docosa-4,7,10,13,16,19-hexaenoic acid hexadecanoic acid Show first 5 Terms
inverse is_conjugate_base_of: 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine(1-)

1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine(1-) Show first 5 Terms
is_conjugate_acid_of: 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine(1-)

1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine(1-) Show first 5 Terms

Phenotype

Phenotype resulting from 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine

Phenotype where environments contain 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine

Phenotype modified by environments containing 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine

Human Disease Model